TRIS PHARMA, INC. AND ITS WHOLLY OWNED SUBSIDIARY ADNEURIS THERAPEUTICS FKA TRIS

Lobbying client · New Jersey · filed 2025 to 2026

Biopharmaceutical company.

$300,000 Reported spend

6 Filings counted

1 Firms hired

2 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (60968), not by name.

Firms hired 1

AEGIS LLC $300,000 6 filings

Bills named in these filings 2

HR 1227
Alternatives to PAIN Act

6 filings
S 475
Alternatives to PAIN Act

6 filings

Reported by year 2 years

2026 $100,000 2 filings
2025 $200,000 4 filings

Issues lobbied 1

Pharmacy 6

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 3

HOUSE OF REPRESENTATIVES 6
SENATE 6
Natl Highway Traffic Safety Administration (NHTSA) 3

Recent filings 6 total

Q2

AEGIS LLC

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $50,000 income · posted Jul 2, 2026

View → Q1

AEGIS LLC

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $50,000 income · posted Apr 7, 2026

View → Q4

AEGIS LLC

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $50,000 income · posted Jan 12, 2026

View → Q3

AEGIS LLC

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $50,000 income · posted Oct 10, 2025

View → Q2

AEGIS LLC

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $50,000 income · posted Jul 18, 2025

View → Q1

AEGIS LLC

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $50,000 income · posted Apr 4, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.